+499.5%
MRNA vs VCLT
-0.4%
+499.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VCLT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.1% | -2.3% | -3.0% |
| 7D | +5.5% | -0.5% | +6.0% | +8.5% |
| 30D | +158.7% | -0.9% | +159.6% | +175.1% |
| 3M | +182.1% | -3.2% | +185.4% | +220.9% |
| 6M | +151.8% | -3.8% | +155.6% | +193.9% |
| YTD | +393.6% | -2.0% | +395.6% | +450.8% |
| 1Y | +499.5% | -0.8% | +500.3% | +540.4% |
| All | +499.5% | -0.4% | +499.9% | +540.4% |
Cumulative growth
Daily Returns
Daily percentage return beside VCLT.
Daily Out/Under-Performance
Portfolio return minus VCLT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VCLT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VCLT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling